A niche player $IRMD (-1,34%) in the healthcare sector; strong quarter, but management has slightly lowered its guidance. If the stock price drops a bit more, the valuation could become attractive again...
2Settimana·
Iradimed Q3/26 Earnings
33
2 CommentiBrian@Aktienhauptmeister
2Settimana
•
22
•Stocktective@Stocktective
2Settimana
••